Cell Biotech earns patent for inflammatory bowel disease treatment
By 박윤아Published : Sept. 5, 2016 - 10:35
[DISCLOSURE] Cell Biotech (049960) said on Sept. 5 that it has acquired a patent for a composition that prevents and treats inflammatory bowel disease, based on four kinds of probiotics lactic acid bacteria that the company owns.
By Park Yuna (yunapark@heraldcorp.com)
By Park Yuna (yunapark@heraldcorp.com)